Virtual meeting

It was concluded that the C max and AUC changes of digoxin after GLP-1 RA administration may not be clinically significant.55,56,58,150,153 Likewise, the pharmacokinetics of warfarin were not altered by semaglutide administration.158,159 The AUC of S- and R-warfarin was not affected by dulaglutide and tirzepatide administration.55,58 However, postmarketing data on exenatide indicate an increase in INR, which is sometimes associated with bleeding events, highlighting the need for close INR monitoring after GLP-1 RA treatment.36 Furthermore, DDIs between levothyroxine and oral semaglutide, caused by delayed gastric emptying, have been explored (Table 5).160 Levothyroxine, a synthetic form of the thyroid hormone thyroxine, is an orally administered narrow therapeutic index drug used to treat hypothyroidism.170 It has been reported that gastrointestinal motility may affect its bioavailability, and reduced absorption is a leading contributor to refractory hypothyroidism.171,172 Therefore, it is recommended to administer levothyroxine at least 1 h before meals.173 Based on this information, the influence of gastric emptying effect by oral semaglutide administration on pharmacokinetics of levothyroxine was investigated.160 After multiple oral doses of 14 mg oral semaglutide, the T max of levothyroxine was delayed by 2 h, with a 12% decrease in the C max and a 33% increase in the AUC, indicating potential clinical relevance (Table 5)

Light and heat can degrade glutathione, so proper handling matters
Standard supplements often fail to deliver because they cannot survive the digestive process
What retatrutide approval would mean for the market If approved, retatrutide would enter a rapidly evolving landscape of weight loss medications
That stabbing pain you're experiencingthe one that makes those first morning steps absolutely excruciatingI get it